An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
Rosamaria Pennisi, Davide Gentile, Antonio Rescifina, Edoardo Napoli, Paola Trischitta, Anna Piperno, Maria Teresa Sciortino
Biomolecules, doi:10.3390/biom14010043
Coronavirus disease 2019 (COVID-19) , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a specific therapeutic agent. 3CL pro (also known as the main protease or M pro ) and PL pro are chymotrypsin-like proteases encoded by the SARS-CoV-2 genome, and play essential roles during the virus lifecycle. Therefore, they are recognized as a prospective therapeutic target in drug discovery against SARS-CoV-2 infection. Thus, this work aims to collectively present potential natural 3CL pro and PL pro inhibitors by in silico simulations and in vitro entry pseudotype-entry models. We screened luteolin-7-O-glucuronide (L7OG), cynarin (CY), folic acid (FA), and rosmarinic acid (RA) molecules against PL pro and 3CL pro through a luminogenic substrate assay. We only reported moderate inhibitory activity on the recombinant 3CL pro and PL pro by L7OG and FA. Afterward, the entry inhibitory activity of L7OG and FA was tested in cell lines transduced with the two different SARS-CoV-2 pseudotypes harboring alpha (α) and omicron (o) spike (S) protein. The results showed that both compounds have a consistent inhibitory activity on the entry for both variants. However, L7OG showed a greater degree of entry inhibition against α-SARS-CoV-2. Molecular modeling studies were used to determine the inhibitory mechanism of the candidate molecules by focusing on their interactions with residues recognized by the protease active site and receptor-binding domain (RBD) of spike SARS-CoV-2. This work allowed us to identify the binding sites of FA and L7OG within the RBD domain in the alpha and omicron variants, demonstrating how FA is active in both variants. We have confidence that future in vivo studies testing the safety and effectiveness of these natural compounds are warranted, given that they are effective against a variant of concerns.
Conflicts of Interest: The authors declare no conflict of interest.
References
Alvarado, Perez-Lemus, Menéndez, Byléhn, De Pablo, Molecular Characterization of COVID-19 Therapeutics: Luteolin as an Allosteric Modulator of the Spike Protein of SARS-CoV-2, Mol. Syst. Des. Eng,
doi:10.1039/D1ME00119ABontempo, De Masi, Rigano, Functional Properties of Natural Products and Human Health, Nutrients,
doi:10.3390/nu15132961Citarella, Dimasi, Moi, Passarella, Scala et al., Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives, Biomolecules,
doi:10.3390/biom13091339Citarella, Gentile, Rescifina, Piperno, Mognetti et al., Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses, Int. J. Mol. Sci,
doi:10.3390/ijms22031398Daniloski, Jordan, Wessels, Hoagland, Kasela et al., Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells, Cell,
doi:10.1016/j.cell.2020.10.030Dissook, Umsumarng, Mapoung, Semmarath, Arjsri et al., Luteolin-Rich Fraction from Perilla Frutescens Seed Meal Inhibits Spike Glycoprotein S1 of SARS-CoV-2-Induced NLRP3 Inflammasome Lung Cell Inflammation via Regulation of JAK1/STAT3 Pathway: A Potential Anti-Inflammatory Compound against Inflammation-Induced Long-COVID, Front. Med,
doi:10.3389/fmed.2022.1072056Duan, Wu, Chowdhury, Lee, Xiong et al., A Point-charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-phase Quantum Mechanical Calculations, J. Comput. Chem,
doi:10.1002/jcc.10349Essmann, Perera, Berkowitz, Darden, Lee et al., A Smooth Particle Mesh Ewald Method, J. Chem. Phys,
doi:10.1063/1.470117Floresta, Amata, Barbaraci, Gentile, Turnaturi et al., A Structure-and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands, Mar. Drugs,
doi:10.3390/md16100384Floresta, Dichiara, Gentile, Prezzavento, Marrazzo et al., Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands, Int. J. Mol. Sci,
doi:10.3390/ijms20030488Floresta, Patamia, Gentile, Molteni, Santamato et al., Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach, ChemMedChem,
doi:10.1002/cmdc.201900594Galimberti, Barbera, Guerra, Bernardi, Facile functionalization of sp2 carbon allotropes with a biobased janus molecule, Rubber Chem. Technol,
doi:10.5254/rct.17.82665Gentile, Floresta, Patamia, Chiaramonte, Mauro et al., An Integrated Pharmacophore/ Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin a Inhibitors, Int. J. Mol. Sci,
doi:10.3390/ijms21249470Gentile, Floresta, Patamia, Nicosia, Mineo et al., Cucurbit[7]Uril as a Catalytic Nanoreactor for One-Pot Synthesis of Isoxazolidines in Water, Org. Biomol. Chem,
doi:10.1039/C9OB02352FGentile, Patamia, Fuochi, Furneri, Rescifina, Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects, Curr. Med. Chem,
doi:10.2174/0929867328666210614114032Gezer, Potential Health Effects of the Popular Compound of Artichoke: Cynarin (CYN), Prog. Nutr
Heleno, Carocho, Reis, Pires, Pintado et al., Plant Extracts and SARS-CoV-2: Research and Applications, Life,
doi:10.3390/life13020386Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell,
doi:10.1016/j.cell.2020.02.052Hornak, Abel, Okur, Strockbine, Roitberg et al., Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters, Proteins Struct. Funct. Bioinform,
doi:10.1002/prot.21123Jakalian, Jack, Bayly, Fast, Efficient Generation of High-quality Atomic Charges. AM1-BCC Model: II. Parameterization and Validation, J. Comput. Chem,
doi:10.1002/jcc.10128Júnior, De Sousa Junior, Nze, Giozza, Júnior, Evaluation of Peppermint Leaf Flavonoids as SARS-CoV-2 Spike Receptor-Binding Domain Attachment Inhibitors to the Human ACE2 Receptor: A Molecular Docking Study, Open J. Biophys,
doi:10.4236/ojbiphy.2022.122005Karakousis, Gourgoulianis, Kotsiou, The Role of Folic Acid in SARS-CoV-2 Infection: An Intriguing Linkage under Investigation, J. Pers. Med,
doi:10.3390/jpm13030561Kaur, Sarma, Bhattacharyya, Prajapat, Kumar et al., Folic Acid as Placebo in Controlled Clinical Trials of Hydroxychloroquine Prophylaxis in COVID-19: Is It Scientifically Justifiable?, Med. Hypotheses,
doi:10.1016/j.mehy.2021.110539Krieger, Dunbrack, Hooft, Krieger, Assignment of Protonation States in Proteins and Ligands: Combining PKa Prediction with Hydrogen Bonding Network Optimization
Krieger, Vriend, New Ways to Boost Molecular Dynamics Simulations, J. Comput. Chem,
doi:10.1002/jcc.23899Krüger, Kronenberger, Xie, Rocha, Pöhlmann et al., Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19, Pharmaceuticals,
doi:10.3390/ph16020190Magi, Marini, Brenciani, Di Lodovico, Gentile et al., Chemical Composition of Pistacia vera L. Oleoresin and Its Antibacterial, Anti-Virulence and Anti-Biofilm Activities against Oral Streptococci, Including Streptococcus Mutans, Arch. Oral Biol,
doi:10.1016/j.archoralbio.2018.09.013Maier, Martinez, Kasavajhala, Wickstrom, Hauser et al., Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB, J. Chem. Theory Comput,
doi:10.1021/acs.jctc.5b00255Meng, Abdullahi, Ferreira, Goonawardane, Saito et al., Altered TMPRSS2 Usage by SARS-CoV-2 Omicron Impacts Infectivity and Fusogenicity, Nature,
doi:10.1038/s41586-022-04474-xMetzdorf, Jacobsen, Greweling-Pils, Hoffmann, Lüddecke et al., TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection, Viruses,
doi:10.3390/v15020271Millet, Tang, Nathan, Jaimes, Hsu et al., Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting, J. Vis. Exp,
doi:10.3791/59010Millet, Whittaker, Murine Leukemia Virus (MLV)-Based Coronavirus Spike-Pseudotyped Particle Production and Infection, Bio Protoc,
doi:10.21769/BioProtoc.2035Mukherjee, Dikic, Proteases of SARS Coronaviruses
Munafò, Donati, Brindani, Ottonello, Armirotti et al., Quercetin and Luteolin Are Single-Digit Micromolar Inhibitors of the SARS-CoV-2 RNA-Dependent RNA Polymerase, Sci. Rep,
doi:10.1038/s41598-022-14664-2Muruganathan, Dhanapal, Baskar, Muthuramalingam, Selvaraj et al., Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review, Metabolites,
doi:10.3390/metabo12111145Musarra-Pizzo, Pennisi, Ben-Amor, Mandalari, Sciortino, Antiviral Activity Exerted by Natural Products against Human Viruses, Viruses,
doi:10.3390/v13050828Narayanan, Narwal, Majowicz, Varricchio, Toner et al., Identification of SARS-CoV-2 Inhibitors Targeting Mpro and PLpro Using in-Cell-Protease Assay, Commun. Biol,
doi:10.1038/s42003-022-03090-9Ou, Lan, Wu, Zhao, Duan et al., Tracking SARS-CoV-2 Omicron Diverse Spike Gene Mutations Identifies Multiple Inter-Variant Recombination Events, Signal Transduct. Target. Ther,
doi:10.1038/s41392-022-00992-2Pennisi, Trischitta, Tamburello, Barreca, Mandalari et al., Mechanistic Understanding of the Antiviral Properties of Pistachios and Zeaxanthin against HSV-1, Viruses,
doi:10.3390/v15081651Pišlar, Mitrović, Sabotič, Pečar Fonović, Perišić Nanut et al., The Role of Cysteine Peptidases in Coronavirus Cell Entry and Replication: The Therapeutic Potential of Cathepsin Inhibitors, PLoS Pathog,
doi:10.1371/journal.ppat.1009013Prasansuklab, Theerasri, Rangsinth, Sillapachaiyaporn, Chuchawankul et al., Anti-COVID-19 Drug Candidates: A Review on Potential Biological Activities of Natural Products in the Management of New Coronavirus Infection, J. Tradit. Complement. Med,
doi:10.1016/j.jtcme.2020.12.001Sacco, Ma, Lagarias, Gao, Townsend et al., Structure and Inhibition of the SARS-CoV-2 Main Protease Reveal Strategy for Developing Dual Inhibitors against M pro and Cathepsin L, Sci. Adv,
doi:10.1126/sciadv.abe0751Seth, Batra, Srinivasan, COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response, Front. Mol. Biosci,
doi:10.3389/fmolb.2020.00215Shawan, Halder, Hasan, Luteolin and Abyssinone II as Potential Inhibitors of SARS-CoV-2: An in Silico Molecular Modeling Approach in Battling the COVID-19 Outbreak, Bull. Natl. Res. Cent,
doi:10.1186/s42269-020-00479-6Tang, Jaimes, Bidon, Straus, Daniel et al., Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin, ACS Infect. Dis,
doi:10.1021/acsinfecdis.0c00701Toelzer, Gupta, Yadav, Borucu, Davidson et al., Free Fatty Acid Binding Pocket in the Locked Structure of SARS-CoV-2 Spike Protein, Science,
doi:10.1126/science.abd3255Ugurel, Mutlu, Sariyer, Kocer, Ugurel et al., Evaluation of the Potency of FDA-Approved Drugs on Wild Type and Mutant SARS-CoV-2 Helicase (Nsp13), Int. J. Biol. Macromol,
doi:10.1016/j.ijbiomac.2020.09.138Wang, Wolf, Caldwell, Kollman, Case, Development and Testing of a General Amber Force Field, J. Comput. Chem,
doi:10.1002/jcc.20035Wang, Yang, Liu, Guo, Zhang et al., SARS Coronavirus Entry into Host Cells through a Novel Clathrin-and Caveolae-Independent Endocytic Pathway, Cell Res,
doi:10.1038/cr.2008.15Watanabe, Matsuyama, Shirato, Maejima, Fukushi et al., Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein, J. Virol,
doi:10.1128/JVI.01412-08Xiang, Li, Wu, Tian, Fu, Application of Pseudovirus System in the Development of Vaccine, Antiviral-Drugs, and Neutralizing Antibodies, Microbiol. Res,
doi:10.1016/j.micres.2022.126993Zhang, Pang, Xu, Chen, Liang et al., Folic Acid Restricts SARS-CoV-2 Invasion by Methylating ACE2, Front. Microbiol,
doi:10.3389/fmicb.2022.980903Zhang, Zhao, Liu, He, Yu et al., Design of SARS-CoV-2 Mpro, PLpro Dual-Target Inhibitors Based on Deep Reinforcement Learning and Virtual Screening, Future Med. Chem,
doi:10.4155/fmc-2021-0269Zhu, Yan, Shi, Zhang, Lu et al., Luteolin Inhibits Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Binding to Angiotensin-converting Enzyme 2, Phytother. Res,
doi:10.1002/ptr.7826Škrbić, Travar, Stojiljković, Djuric, Suručić, Folic Acid and Leucovorin Have Potential to Prevent SARS-CoV-2-Virus Internalization by Interacting with S-Glycoprotein/Neuropilin-1 Receptor Complex, Molecules,
doi:10.3390/molecules28052294{ 'indexed': { 'date-parts': [[2023, 12, 29]],
'date-time': '2023-12-29T00:34:57Z',
'timestamp': 1703810097028},
'reference-count': 59,
'publisher': 'MDPI AG',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2023, 12, 28]],
'date-time': '2023-12-28T00:00:00Z',
'timestamp': 1703721600000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'funder': [ { 'name': 'FFABR-Sciortino_Maria_Teresa_2020_II_Edizione (Italy).',
'award': ['FFABR-Sciortino_Maria_Teresa_2020_II_Edizione (Italy).']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome '
'coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a '
'specific therapeutic agent. 3CLpro (also known as the main protease or Mpro) and PLpro are '
'chymotrypsin-like proteases encoded by the SARS-CoV-2 genome, and play essential roles during '
'the virus lifecycle. Therefore, they are recognized as a prospective therapeutic target in '
'drug discovery against SARS-CoV-2 infection. Thus, this work aims to collectively present '
'potential natural 3CLpro and PLpro inhibitors by in silico simulations and in vitro entry '
'pseudotype-entry models. We screened luteolin-7-O-glucuronide (L7OG), cynarin (CY), folic '
'acid (FA), and rosmarinic acid (RA) molecules against PLpro and 3CLpro through a luminogenic '
'substrate assay. We only reported moderate inhibitory activity on the recombinant 3CLpro and '
'PLpro by L7OG and FA. Afterward, the entry inhibitory activity of L7OG and FA was tested in '
'cell lines transduced with the two different SARS-CoV-2 pseudotypes harboring alpha (α) and '
'omicron (o) spike (S) protein. The results showed that both compounds have a consistent '
'inhibitory activity on the entry for both variants. However, L7OG showed a greater degree of '
'entry inhibition against α-SARS-CoV-2. Molecular modeling studies were used to determine the '
'inhibitory mechanism of the candidate molecules by focusing on their interactions with '
'residues recognized by the protease active site and receptor-binding domain (RBD) of spike '
'SARS-CoV-2. This work allowed us to identify the binding sites of FA and L7OG within the RBD '
'domain in the alpha and omicron variants, demonstrating how FA is active in both variants. We '
'have confidence that future in vivo studies testing the safety and effectiveness of these '
'natural compounds are warranted, given that they are effective against a variant of '
'concerns.</jats:p>',
'DOI': '10.3390/biom14010043',
'type': 'journal-article',
'created': { 'date-parts': [[2023, 12, 28]],
'date-time': '2023-12-28T14:35:21Z',
'timestamp': 1703774121000},
'page': '43',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active '
'against SARS-CoV-2',
'prefix': '10.3390',
'volume': '14',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-3474-6057',
'authenticated-orcid': False,
'given': 'Rosamaria',
'family': 'Pennisi',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Chemical, Biological, Pharmaceutical and '
'Environmental Science, University of Messina, Viale Ferdinando '
'Stagno d’Alcontres 31, 98166 Messina, Italy'}]},
{ 'given': 'Davide',
'family': 'Gentile',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Chemistry, Materials and Chemical Engineering “G. '
'Natta”, Politecnico di Milano, Via Mancinelli 7, 20131 Milano, '
'Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-5039-2151',
'authenticated-orcid': False,
'given': 'Antonio',
'family': 'Rescifina',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Drug and Health Sciences, University of Catania, '
'V.le A. Doria 6, 95125 Catania, Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-4281-3256',
'authenticated-orcid': False,
'given': 'Edoardo',
'family': 'Napoli',
'sequence': 'additional',
'affiliation': [ { 'name': 'Istituto di Chimica Biomolecolare—Consiglio Nazionale delle '
'Ricerche, 95126 Catania, Italy'}]},
{ 'given': 'Paola',
'family': 'Trischitta',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Chemical, Biological, Pharmaceutical and '
'Environmental Science, University of Messina, Viale Ferdinando '
'Stagno d’Alcontres 31, 98166 Messina, Italy'},
{ 'name': 'Department of Chemistry, Biology and Biotechnology, University '
'of Perugia, Via Elce di Sotto 8, 06123 Perugia, Italy'}]},
{ 'given': 'Anna',
'family': 'Piperno',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Chemical, Biological, Pharmaceutical and '
'Environmental Science, University of Messina, Viale Ferdinando '
'Stagno d’Alcontres 31, 98166 Messina, Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-8519-7724',
'authenticated-orcid': False,
'given': 'Maria Teresa',
'family': 'Sciortino',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Chemical, Biological, Pharmaceutical and '
'Environmental Science, University of Messina, Viale Ferdinando '
'Stagno d’Alcontres 31, 98166 Messina, Italy'}]}],
'member': '1968',
'published-online': {'date-parts': [[2023, 12, 28]]},
'reference': [ { 'key': 'ref_1',
'unstructured': 'Mukherjee, R., and Dikic, I. (2023). Encyclopedia of Cell Biology, '
'Elsevier.'},
{ 'key': 'ref_2',
'doi-asserted-by': 'crossref',
'first-page': '1221',
'DOI': '10.3389/fchem.2021.819165',
'article-title': 'Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development',
'volume': '9',
'author': 'Lv',
'year': '2022',
'journal-title': 'Front. Chem.'},
{ 'key': 'ref_3',
'doi-asserted-by': 'crossref',
'unstructured': 'Narayanan, A., Narwal, M., Majowicz, S.A., Varricchio, C., Toner, S.A., '
'Ballatore, C., Brancale, A., Murakami, K.S., and Jose, J. (2022). '
'Identification of SARS-CoV-2 Inhibitors Targeting Mpro and PLpro Using '
'in-Cell-Protease Assay. Commun. Biol., 5.',
'DOI': '10.1038/s42003-022-03090-9'},
{ 'key': 'ref_4',
'doi-asserted-by': 'crossref',
'unstructured': 'Citarella, A., Gentile, D., Rescifina, A., Piperno, A., Mognetti, B., '
'Gribaudo, G., Sciortino, M.T., Holzer, W., Pace, V., and Micale, N. '
'(2021). Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as '
'Electrophilic Warhead with Activity against Coronaviruses. Int. J. Mol. '
'Sci., 22.',
'DOI': '10.3390/ijms22031398'},
{ 'key': 'ref_5',
'doi-asserted-by': 'crossref',
'unstructured': 'Citarella, A., Dimasi, A., Moi, D., Passarella, D., Scala, A., Piperno, '
'A., and Micale, N. (2023). Recent Advances in SARS-CoV-2 Main Protease '
'Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules, 13.',
'DOI': '10.20944/preprints202308.0055.v1'},
{ 'key': 'ref_6',
'doi-asserted-by': 'crossref',
'first-page': '393',
'DOI': '10.4155/fmc-2021-0269',
'article-title': 'Design of SARS-CoV-2 Mpro, PLpro Dual-Target Inhibitors Based on Deep '
'Reinforcement Learning and Virtual Screening',
'volume': '14',
'author': 'Zhang',
'year': '2022',
'journal-title': 'Future Med. Chem.'},
{ 'key': 'ref_7',
'doi-asserted-by': 'crossref',
'first-page': 'eabe0751',
'DOI': '10.1126/sciadv.abe0751',
'article-title': 'Structure and Inhibition of the SARS-CoV-2 Main Protease Reveal '
'Strategy for Developing Dual Inhibitors against Mpro and Cathepsin L',
'volume': '6',
'author': 'Sacco',
'year': '2020',
'journal-title': 'Sci. Adv.'},
{ 'key': 'ref_8',
'doi-asserted-by': 'crossref',
'first-page': '92',
'DOI': '10.1016/j.cell.2020.10.030',
'article-title': 'Identification of Required Host Factors for SARS-CoV-2 Infection in '
'Human Cells',
'volume': '184',
'author': 'Daniloski',
'year': '2021',
'journal-title': 'Cell'},
{ 'key': 'ref_9',
'doi-asserted-by': 'crossref',
'first-page': '271',
'DOI': '10.1016/j.cell.2020.02.052',
'article-title': 'SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a '
'Clinically Proven Protease Inhibitor',
'volume': '181',
'author': 'Hoffmann',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': 'ref_10',
'doi-asserted-by': 'crossref',
'unstructured': 'Pišlar, A., Mitrović, A., Sabotič, J., Pečar Fonović, U., Perišić Nanut, '
'M., Jakoš, T., Senjor, E., and Kos, J. (2020). The Role of Cysteine '
'Peptidases in Coronavirus Cell Entry and Replication: The Therapeutic '
'Potential of Cathepsin Inhibitors. PLoS Pathog., 16.',
'DOI': '10.1371/journal.ppat.1009013'},
{ 'key': 'ref_11',
'doi-asserted-by': 'crossref',
'first-page': '264',
'DOI': '10.1021/acsinfecdis.0c00701',
'article-title': 'Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: '
'Potential Role of Proteases beyond Furin',
'volume': '7',
'author': 'Tang',
'year': '2021',
'journal-title': 'ACS Infect. Dis.'},
{ 'key': 'ref_12',
'doi-asserted-by': 'crossref',
'unstructured': 'Seth, S., Batra, J., and Srinivasan, S. (2020). COVID-19: Targeting '
'Proteases in Viral Invasion and Host Immune Response. Front. Mol. '
'Biosci., 7.',
'DOI': '10.3389/fmolb.2020.00215'},
{ 'key': 'ref_13',
'doi-asserted-by': 'crossref',
'unstructured': 'Bontempo, P., De Masi, L., and Rigano, D. (2023). Functional Properties '
'of Natural Products and Human Health. Nutrients, 15.',
'DOI': '10.3390/nu15132961'},
{ 'key': 'ref_14',
'doi-asserted-by': 'crossref',
'first-page': '208',
'DOI': '10.1016/j.archoralbio.2018.09.013',
'article-title': 'Chemical Composition of Pistacia vera L. Oleoresin and Its '
'Antibacterial, Anti-Virulence and Anti-Biofilm Activities against Oral '
'Streptococci, Including Streptococcus Mutans',
'volume': '96',
'author': 'Magi',
'year': '2018',
'journal-title': 'Arch. Oral Biol.'},
{ 'key': 'ref_15',
'doi-asserted-by': 'crossref',
'unstructured': 'Musarra-Pizzo, M., Pennisi, R., Ben-Amor, I., Mandalari, G., and '
'Sciortino, M.T. (2021). Antiviral Activity Exerted by Natural Products '
'against Human Viruses. Viruses, 13.',
'DOI': '10.3390/v13050828'},
{ 'key': 'ref_16',
'doi-asserted-by': 'crossref',
'first-page': '144',
'DOI': '10.1016/j.jtcme.2020.12.001',
'article-title': 'Anti-COVID-19 Drug Candidates: A Review on Potential Biological '
'Activities of Natural Products in the Management of New Coronavirus '
'Infection',
'volume': '11',
'author': 'Prasansuklab',
'year': '2021',
'journal-title': 'J. Tradit. Complement. Med.'},
{ 'key': 'ref_17',
'doi-asserted-by': 'crossref',
'unstructured': 'Muruganathan, N., Dhanapal, A.R., Baskar, V., Muthuramalingam, P., '
'Selvaraj, D., Aara, H., Shiek Abdullah, M.Z., and Sivanesan, I. (2022). '
'Recent Updates on Source, Biosynthesis, and Therapeutic Potential of '
'Natural Flavonoid Luteolin: A Review. Metabolites, 12.',
'DOI': '10.3390/metabo12111145'},
{ 'key': 'ref_18',
'doi-asserted-by': 'crossref',
'first-page': '3508',
'DOI': '10.1002/ptr.7826',
'article-title': 'Luteolin Inhibits Spike Protein of Severe Acute Respiratory Syndrome '
'Coronavirus-2 (SARS-CoV-2) Binding to Angiotensin-converting Enzyme 2',
'volume': '37',
'author': 'Zhu',
'year': '2023',
'journal-title': 'Phytother. Res.'},
{ 'key': 'ref_19',
'first-page': '5',
'article-title': 'Potential Health Effects of the Popular Compound of Artichoke: Cynarin '
'(CYN)',
'volume': '19',
'author': 'Gezer',
'year': '2017',
'journal-title': 'Prog. Nutr.'},
{ 'key': 'ref_20',
'doi-asserted-by': 'crossref',
'unstructured': 'Heleno, S.A., Carocho, M., Reis, F.S., Pires, T.C.S.P., Pintado, M., '
'Ferreira, I.C.F.R., and Barros, L. (2023). Plant Extracts and '
'SARS-CoV-2: Research and Applications. Life, 13.',
'DOI': '10.3390/life13020386'},
{ 'key': 'ref_21',
'doi-asserted-by': 'crossref',
'unstructured': 'Karakousis, N.D., Gourgoulianis, K.I., and Kotsiou, O.S. (2023). The '
'Role of Folic Acid in SARS-CoV-2 Infection: An Intriguing Linkage under '
'Investigation. J. Pers. Med., 13.',
'DOI': '10.3390/jpm13030561'},
{ 'key': 'ref_22',
'doi-asserted-by': 'crossref',
'unstructured': 'Krüger, N., Kronenberger, T., Xie, H., Rocha, C., Pöhlmann, S., Su, H., '
'Xu, Y., Laufer, S.A., and Pillaiyar, T. (2023). Discovery of '
'Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for '
'COVID-19. Pharmaceuticals, 16.',
'DOI': '10.3390/ph16020190'},
{ 'key': 'ref_23',
'first-page': '725',
'article-title': 'Free Fatty Acid Binding Pocket in the Locked Structure of SARS-CoV-2 '
'Spike Protein',
'volume': '370',
'author': 'Toelzer',
'year': '2020',
'journal-title': 'Science (1979)'},
{ 'key': 'ref_24',
'doi-asserted-by': 'crossref',
'unstructured': 'Floresta, G., Dichiara, M., Gentile, D., Prezzavento, O., Marrazzo, A., '
'Rescifina, A., and Amata, E. (2019). Morphing of Ibogaine: A Successful '
'Attempt into the Search for Sigma-2 Receptor Ligands. Int. J. Mol. Sci., '
'20.',
'DOI': '10.3390/ijms20030488'},
{ 'key': 'ref_25',
'doi-asserted-by': 'crossref',
'first-page': '862',
'DOI': '10.1080/13880209.2022.2063341',
'article-title': 'Folic Acid: A Potential Inhibitor against SARS-CoV-2 Nucleocapsid '
'Protein',
'volume': '60',
'author': 'Chen',
'year': '2022',
'journal-title': 'Pharm. Biol.'},
{ 'key': 'ref_26',
'doi-asserted-by': 'crossref',
'first-page': '8333',
'DOI': '10.2174/0929867328666210614114032',
'article-title': 'Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation '
'Resulting from the Cross-Fertilization of Molecular Modeling Data with '
'the Pharmacological Aspects',
'volume': '28',
'author': 'Gentile',
'year': '2021',
'journal-title': 'Curr. Med. Chem.'},
{ 'key': 'ref_27',
'doi-asserted-by': 'crossref',
'first-page': '11985',
'DOI': '10.1128/JVI.01412-08',
'article-title': 'Entry from the Cell Surface of Severe Acute Respiratory Syndrome '
'Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus '
'Bearing Cleaved S Protein',
'volume': '82',
'author': 'Watanabe',
'year': '2008',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_28',
'doi-asserted-by': 'crossref',
'first-page': '290',
'DOI': '10.1038/cr.2008.15',
'article-title': 'SARS Coronavirus Entry into Host Cells through a Novel Clathrin- and '
'Caveolae-Independent Endocytic Pathway',
'volume': '18',
'author': 'Wang',
'year': '2008',
'journal-title': 'Cell Res.'},
{ 'key': 'ref_29',
'doi-asserted-by': 'crossref',
'unstructured': 'Xiang, Q., Li, L., Wu, J., Tian, M., and Fu, Y. (2022). Application of '
'Pseudovirus System in the Development of Vaccine, Antiviral-Drugs, and '
'Neutralizing Antibodies. Microbiol. Res., 258.',
'DOI': '10.1016/j.micres.2022.126993'},
{ 'key': 'ref_30',
'doi-asserted-by': 'crossref',
'unstructured': 'Pennisi, R., Trischitta, P., Tamburello, M.P., Barreca, D., Mandalari, '
'G., and Sciortino, M.T. (2023). Mechanistic Understanding of the '
'Antiviral Properties of Pistachios and Zeaxanthin against HSV-1. '
'Viruses, 15.',
'DOI': '10.3390/v15081651'},
{ 'key': 'ref_31',
'doi-asserted-by': 'crossref',
'unstructured': 'Millet, J., and Whittaker, G. (2016). Murine Leukemia Virus (MLV)-Based '
'Coronavirus Spike-Pseudotyped Particle Production and Infection. Bio '
'Protoc., 6.',
'DOI': '10.21769/BioProtoc.2035'},
{ 'key': 'ref_32',
'first-page': 'e59010',
'article-title': 'Production of Pseudotyped Particles to Study Highly Pathogenic '
'Coronaviruses in a Biosafety Level 2 Setting',
'volume': '145',
'author': 'Millet',
'year': '2019',
'journal-title': 'J. Vis. Exp.'},
{ 'key': 'ref_33',
'doi-asserted-by': 'crossref',
'first-page': '1194',
'DOI': '10.1039/C9OB02352F',
'article-title': 'Cucurbit[7]Uril as a Catalytic Nanoreactor for One-Pot Synthesis of '
'Isoxazolidines in Water',
'volume': '18',
'author': 'Gentile',
'year': '2020',
'journal-title': 'Org. Biomol. Chem.'},
{ 'key': 'ref_34',
'doi-asserted-by': 'crossref',
'unstructured': 'Floresta, G., Amata, E., Barbaraci, C., Gentile, D., Turnaturi, R., '
'Marrazzo, A., and Rescifina, A. (2018). A Structure- and Ligand-Based '
'Virtual Screening of a Database of “Small” Marine Natural Products for '
'the Identification of “Blue” Sigma-2 Receptor Ligands. Mar. Drugs, 16.',
'DOI': '10.3390/md16100384'},
{ 'key': 'ref_35',
'doi-asserted-by': 'crossref',
'unstructured': 'Gentile, D., Floresta, G., Patamia, V., Chiaramonte, R., Mauro, G.L., '
'Rescifina, A., and Vecchio, M. (2020). An Integrated '
'Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of '
'Products in Search of Future Botulinum Neurotoxin a Inhibitors. Int. J. '
'Mol. Sci., 21.',
'DOI': '10.3390/ijms21249470'},
{ 'key': 'ref_36',
'doi-asserted-by': 'crossref',
'first-page': '256',
'DOI': '10.1002/cmdc.201900594',
'article-title': 'Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A '
'Paired 3D-QSAR/Docking Approach',
'volume': '15',
'author': 'Floresta',
'year': '2020',
'journal-title': 'ChemMedChem'},
{ 'key': 'ref_37',
'doi-asserted-by': 'crossref',
'first-page': '1999',
'DOI': '10.1002/jcc.10349',
'article-title': 'A Point-charge Force Field for Molecular Mechanics Simulations of '
'Proteins Based on Condensed-phase Quantum Mechanical Calculations',
'volume': '24',
'author': 'Duan',
'year': '2003',
'journal-title': 'J. Comput. Chem.'},
{ 'key': 'ref_38',
'unstructured': 'Krieger, E., Dunbrack, R.L., Hooft, R.W.W., and Krieger, B. (2012). '
'Computational Drug Discovery and Design, Springer.'},
{ 'key': 'ref_39',
'doi-asserted-by': 'crossref',
'first-page': '481',
'DOI': '10.1016/j.jmgm.2006.02.009',
'article-title': 'Fast Empirical PKa Prediction by Ewald Summation',
'volume': '25',
'author': 'Krieger',
'year': '2006',
'journal-title': 'J. Mol. Graph. Model.'},
{ 'key': 'ref_40',
'doi-asserted-by': 'crossref',
'first-page': '3696',
'DOI': '10.1021/acs.jctc.5b00255',
'article-title': 'Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone '
'Parameters from Ff99SB',
'volume': '11',
'author': 'Maier',
'year': '2015',
'journal-title': 'J. Chem. Theory Comput.'},
{ 'key': 'ref_41',
'doi-asserted-by': 'crossref',
'first-page': '1157',
'DOI': '10.1002/jcc.20035',
'article-title': 'Development and Testing of a General Amber Force Field',
'volume': '25',
'author': 'Wang',
'year': '2004',
'journal-title': 'J. Comput. Chem.'},
{ 'key': 'ref_42',
'doi-asserted-by': 'crossref',
'first-page': '1623',
'DOI': '10.1002/jcc.10128',
'article-title': 'Fast, Efficient Generation of High-quality Atomic Charges. AM1-BCC '
'Model: II. Parameterization and Validation',
'volume': '23',
'author': 'Jakalian',
'year': '2002',
'journal-title': 'J. Comput. Chem.'},
{ 'key': 'ref_43',
'doi-asserted-by': 'crossref',
'first-page': '712',
'DOI': '10.1002/prot.21123',
'article-title': 'Comparison of Multiple Amber Force Fields and Development of Improved '
'Protein Backbone Parameters',
'volume': '65',
'author': 'Hornak',
'year': '2006',
'journal-title': 'Proteins Struct. Funct. Bioinform.'},
{ 'key': 'ref_44',
'doi-asserted-by': 'crossref',
'first-page': '8577',
'DOI': '10.1063/1.470117',
'article-title': 'A Smooth Particle Mesh Ewald Method',
'volume': '103',
'author': 'Essmann',
'year': '1995',
'journal-title': 'J. Chem. Phys.'},
{ 'key': 'ref_45',
'doi-asserted-by': 'crossref',
'first-page': '996',
'DOI': '10.1002/jcc.23899',
'article-title': 'New Ways to Boost Molecular Dynamics Simulations',
'volume': '36',
'author': 'Krieger',
'year': '2015',
'journal-title': 'J. Comput. Chem.'},
{ 'key': 'ref_46',
'doi-asserted-by': 'crossref',
'first-page': '285',
'DOI': '10.5254/rct.17.82665',
'article-title': 'Facile functionalization of sp2 carbon allotropes with a biobased janus '
'molecule',
'volume': '90',
'author': 'Galimberti',
'year': '2017',
'journal-title': 'Rubber Chem. Technol.'},
{ 'key': 'ref_47',
'doi-asserted-by': 'crossref',
'first-page': '138',
'DOI': '10.1038/s41392-022-00992-2',
'article-title': 'Tracking SARS-CoV-2 Omicron Diverse Spike Gene Mutations Identifies '
'Multiple Inter-Variant Recombination Events',
'volume': '7',
'author': 'Ou',
'year': '2022',
'journal-title': 'Signal Transduct. Target. Ther.'},
{ 'key': 'ref_48',
'doi-asserted-by': 'crossref',
'first-page': '706',
'DOI': '10.1038/s41586-022-04474-x',
'article-title': 'Altered TMPRSS2 Usage by SARS-CoV-2 Omicron Impacts Infectivity and '
'Fusogenicity',
'volume': '603',
'author': 'Meng',
'year': '2022',
'journal-title': 'Nature'},
{ 'key': 'ref_49',
'doi-asserted-by': 'crossref',
'unstructured': 'Metzdorf, K., Jacobsen, H., Greweling-Pils, M.C., Hoffmann, M., '
'Lüddecke, T., Miller, F., Melcher, L., Kempf, A.M., Nehlmeier, I., and '
'Bruder, D. (2023). TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron '
'Infection. Viruses, 15.',
'DOI': '10.3390/v15020271'},
{ 'key': 'ref_50',
'doi-asserted-by': 'crossref',
'first-page': '110539',
'DOI': '10.1016/j.mehy.2021.110539',
'article-title': 'Folic Acid as Placebo in Controlled Clinical Trials of '
'Hydroxychloroquine Prophylaxis in COVID-19: Is It Scientifically '
'Justifiable?',
'volume': '149',
'author': 'Kaur',
'year': '2021',
'journal-title': 'Med. Hypotheses'},
{ 'key': 'ref_51',
'doi-asserted-by': 'crossref',
'first-page': '1687',
'DOI': '10.1016/j.ijbiomac.2020.09.138',
'article-title': 'Evaluation of the Potency of FDA-Approved Drugs on Wild Type and Mutant '
'SARS-CoV-2 Helicase (Nsp13)',
'volume': '163',
'author': 'Ugurel',
'year': '2020',
'journal-title': 'Int. J. Biol. Macromol.'},
{ 'key': 'ref_52',
'doi-asserted-by': 'crossref',
'unstructured': 'Zhang, Y., Pang, Y., Xu, B., Chen, X., Liang, S., Hu, J., and Luo, X. '
'(2022). Folic Acid Restricts SARS-CoV-2 Invasion by Methylating ACE2. '
'Front. Microbiol., 13.',
'DOI': '10.3389/fmicb.2022.980903'},
{ 'key': 'ref_53',
'doi-asserted-by': 'crossref',
'unstructured': 'Škrbić, R., Travar, M., Stojiljković, M.P., Djuric, D.M., and Suručić, '
'R. (2023). Folic Acid and Leucovorin Have Potential to Prevent '
'SARS-CoV-2-Virus Internalization by Interacting with '
'S-Glycoprotein/Neuropilin-1 Receptor Complex. Molecules, 28.',
'DOI': '10.3390/molecules28052294'},
{ 'key': 'ref_54',
'doi-asserted-by': 'crossref',
'first-page': 'e35029',
'DOI': '10.1097/MD.0000000000035029',
'article-title': 'Luteolin Is a Potential Inhibitor of COVID-19: An in Silico Analysis',
'volume': '102',
'author': 'Wang',
'year': '2023',
'journal-title': 'Medicine'},
{ 'key': 'ref_55',
'doi-asserted-by': 'crossref',
'first-page': '132',
'DOI': '10.4236/ojbiphy.2022.122005',
'article-title': 'Evaluation of Peppermint Leaf Flavonoids as SARS-CoV-2 Spike '
'Receptor-Binding Domain Attachment Inhibitors to the Human ACE2 '
'Receptor: A Molecular Docking Study',
'volume': '12',
'author': 'Nze',
'year': '2022',
'journal-title': 'Open J. Biophys.'},
{ 'key': 'ref_56',
'doi-asserted-by': 'crossref',
'first-page': '27',
'DOI': '10.1186/s42269-020-00479-6',
'article-title': 'Luteolin and Abyssinone II as Potential Inhibitors of SARS-CoV-2: An in '
'Silico Molecular Modeling Approach in Battling the COVID-19 Outbreak',
'volume': '45',
'author': 'Shawan',
'year': '2021',
'journal-title': 'Bull. Natl. Res. Cent.'},
{ 'key': 'ref_57',
'doi-asserted-by': 'crossref',
'first-page': '58',
'DOI': '10.1039/D1ME00119A',
'article-title': 'Molecular Characterization of COVID-19 Therapeutics: Luteolin as an '
'Allosteric Modulator of the Spike Protein of SARS-CoV-2',
'volume': '7',
'author': 'Alvarado',
'year': '2022',
'journal-title': 'Mol. Syst. Des. Eng.'},
{ 'key': 'ref_58',
'doi-asserted-by': 'crossref',
'first-page': '10571',
'DOI': '10.1038/s41598-022-14664-2',
'article-title': 'Quercetin and Luteolin Are Single-Digit Micromolar Inhibitors of the '
'SARS-CoV-2 RNA-Dependent RNA Polymerase',
'volume': '12',
'author': 'Donati',
'year': '2022',
'journal-title': 'Sci. Rep.'},
{ 'key': 'ref_59',
'doi-asserted-by': 'crossref',
'first-page': '1072056',
'DOI': '10.3389/fmed.2022.1072056',
'article-title': 'Luteolin-Rich Fraction from Perilla Frutescens Seed Meal Inhibits Spike '
'Glycoprotein S1 of SARS-CoV-2-Induced NLRP3 Inflammasome Lung Cell '
'Inflammation via Regulation of JAK1/STAT3 Pathway: A Potential '
'Anti-Inflammatory Compound against Inflammation-Induced Long-COVID',
'volume': '9',
'author': 'Dissook',
'year': '2023',
'journal-title': 'Front. Med.'}],
'container-title': 'Biomolecules',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/2218-273X/14/1/43/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 12, 28]],
'date-time': '2023-12-28T16:05:28Z',
'timestamp': 1703779528000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/2218-273X/14/1/43'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 12, 28]]},
'references-count': 59,
'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 1]]}},
'alternative-id': ['biom14010043'],
'URL': 'http://dx.doi.org/10.3390/biom14010043',
'relation': {},
'ISSN': ['2218-273X'],
'subject': ['Molecular Biology', 'Biochemistry'],
'container-title-short': 'Biomolecules',
'published': {'date-parts': [[2023, 12, 28]]}}
